150 related articles for article (PubMed ID: 38224370)
1. Impact of radiological and pathological splenic vein involvement in patients with resectable pancreatic body or tail cancer.
Kuriyama N; Mizuno S; Sakamoto T; Fujimura Y; Yuge T; Noguchi D; Ito T; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Nagata M; Usui M; Kishiwada M
Langenbecks Arch Surg; 2024 Jan; 409(1):39. PubMed ID: 38224370
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population.
Tan Q; Chen C; Wang Z; Zhang H; Liu X; Ke N
Eur J Radiol; 2023 Aug; 165():110952. PubMed ID: 37421772
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7047-7058. PubMed ID: 35691957
[TBL] [Abstract][Full Text] [Related]
4. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
Kang JS; Choi YJ; Byun Y; Han Y; Kim JH; Lee JM; Sohn HJ; Kim H; Kwon W; Jang JY
Br J Surg; 2021 Dec; 109(1):105-113. PubMed ID: 34718433
[TBL] [Abstract][Full Text] [Related]
5. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract][Full Text] [Related]
6. Radiographic Splenic Artery Involvement Is a Poor Prognostic Factor in Upfront Surgery for Patients with Resectable Pancreatic Body and Tail Cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Yamaue H
Ann Surg Oncol; 2021 Mar; 28(3):1521-1532. PubMed ID: 32705517
[TBL] [Abstract][Full Text] [Related]
7. Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland.
Hyun JJ; Rose JB; Alseidi AA; Biehl TR; Helton S; Coy DL; Kozarek RA; Rocha FG
J Surg Oncol; 2019 Aug; 120(2):262-269. PubMed ID: 31093997
[TBL] [Abstract][Full Text] [Related]
8. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
Jeune F; Collard M; Augustin J; Guedj N; Marchese U; Rouquette A; Cunha AS; Sebagh M; Pessaux P; Avérous G; Wagner M; Bachet JB; Vaillant JC; Sauvanet A; Gaujoux S
Surgery; 2024 Apr; 175(4):1111-1119. PubMed ID: 38071135
[TBL] [Abstract][Full Text] [Related]
9. Reconsidering resectable oncological conditions in pancreatic tail cancer: A multicenter retrospective study on prognostic factors in pancreatic tail cancer after resection (HOPS Pt-01).
Kimura Y; Nakamura T; Imamura M; Nagayama M; Murakami T; Hayashi T; Kato T; Tanaka K; Yoshida M; Kukita K; Imai K; Yoshida M; Masaki Y; Motoya M; Kuwatani M; Koyama M; Ohnishi H; Takemasa I
Pancreatology; 2024 Feb; 24(1):109-118. PubMed ID: 38103948
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.
Crippa S; Cirocchi R; Maisonneuve P; Partelli S; Pergolini I; Tamburrino D; Aleotti F; Reni M; Falconi M
Eur J Surg Oncol; 2018 Jan; 44(1):24-30. PubMed ID: 29183639
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification.
Morimoto D; Yamada S; Murotani K; Sonohara F; Takami H; Suenaga M; Hayashi M; Niwa Y; Tashiro M; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Pancreas; 2018; 47(10):1350-1356. PubMed ID: 30286011
[TBL] [Abstract][Full Text] [Related]
13. Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram.
Xie T; Xie X; Liu W; Chen L; Liu K; Zhou Z
Eur Radiol; 2023 Nov; 33(11):7782-7793. PubMed ID: 37624415
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer near the splenic hilum has a higher likelihood of splenic vessel invasion and unfavorable survival.
Ueda H; Takahashi H; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Asaoka T; Noda T; Tanemura M; Doki Y; Eguchi H
Langenbecks Arch Surg; 2023 Sep; 408(1):353. PubMed ID: 37695403
[TBL] [Abstract][Full Text] [Related]
16. Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas.
Kanda M; Fujii T; Sahin TT; Kanzaki A; Nagai S; Yamada S; Sugimoto H; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
Ann Surg; 2010 Mar; 251(3):483-7. PubMed ID: 20101172
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail.
Fukami Y; Kaneoka Y; Maeda A; Takayama Y; Onoe S
Int J Surg; 2016 Nov; 35():64-68. PubMed ID: 27646614
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
19. Preoperative gemcitabine-based chemoradiation therapy for pancreatic ductal adenocarcinoma of the body and tail: impact of splenic vessels involvement on operative outcome and pattern of recurrence.
Takahashi H; Akita H; Gotoh K; Kobayashi S; Marubashi S; Miyoshi N; Sugimura K; Motoori M; Kishi K; Noura S; Fujiwara Y; Ohue M; Ohigashi H; Yano M; Sakon M; Ishikawa O
Surgery; 2015 Mar; 157(3):484-95. PubMed ID: 25444512
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of risk factors of postoperative varices after pancreaticoduodenectomy with combined portal vein resection.
Shiihara M; Higuchi R; Izumo W; Yazawa T; Uemura S; Furukawa T; Yamamoto M
Pancreatology; 2020 Apr; 20(3):522-528. PubMed ID: 32111565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
